Liaison Technologies, a US-based provider of cloud-based integration and data management services backed by drugs group Merck, has acquired Hubspan, a local peer backed by chipmaker Intel’s corporate venturing unit, for an undisclosed amount.
Founded in 2000, Hubspan said its investors include Intel Capital as well as venture capital firms Tam Capital (now known as East Peak Capital having been set up by a former Accenture executive, Thomas Cusick), SeaPoint Ventures, Covera Ventures (spun out from conglomerate Hunt Consolidated’s ventures unit in 2009) and Scale Venture Partners.
The company first raised funding in December 2000 from management consultancy Accenture’s Technology Ventures corporate venturing unit, as well as Intel Capital and Seapoint.
Also founded in 2000, Liaison’s backers include second-hand investment firm Verdane Capital Advisors as well as US-listed Merck and logistics company UPS. In April, Liaison said it had met the milestones needed to secure a $30m investment from Merck’s Global Health Innovation Fund.